Acurx Pharmaceuticals Enrolls First Patient in New Clinical Trial for Ibezapolstat to Combat Recurrent C. difficile Infection #United_States #Ibezapolstat #C._difficile #Staten_Island #Acurx_Pharmaceuticals
@newsen.bsky.socialExplore
@newsen.bsky.social@newsen.bsky.socialAcurx Pharmaceuticals Unveils Groundbreaking Findings at C. difficile Symposium on Novel Antibiotic Ibezapolstat #United_States #Ibezapolstat #C._difficile #Staten_Island #Acurx_Pharmaceuticals